Correlation Between ProMIS Neurosciences and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProMIS Neurosciences and Candel Therapeutics, you can compare the effects of market volatilities on ProMIS Neurosciences and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Candel Therapeutics.
Diversification Opportunities for ProMIS Neurosciences and Candel Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ProMIS and Candel is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Candel Therapeutics go up and down completely randomly.
Pair Corralation between ProMIS Neurosciences and Candel Therapeutics
Considering the 90-day investment horizon ProMIS Neurosciences is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ProMIS Neurosciences is 2.0 times less risky than Candel Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 173.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 1,178 from holding Candel Therapeutics or generate 680.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ProMIS Neurosciences vs. Candel Therapeutics
Performance |
| Timeline |
| ProMIS Neurosciences |
| Candel Therapeutics |
ProMIS Neurosciences and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProMIS Neurosciences and Candel Therapeutics
The main advantage of trading using opposite ProMIS Neurosciences and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |